| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |